Furthermore, the levels of IgG, anti-dsDNA and proteinuria were markedly lower in lupus mice treated with atRA/TGF-β-primed CD4+CD25+ cells than in lupus mice treated with TGF-β-primed CD4+CD25+ cells (Figure 2D). This evidence concerns the gene CD4 and systemic lupus erythematosus.